RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Heme Oxygenase-1: Its Therapeutic Roles in Inflammatory Diseases

      한글로보기

      https://www.riss.kr/link?id=A103905302

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Heme oxygenase (HO)-1 is an inducible enzyme that catalyzes the first and rate-limiting step in the oxidative degradation of free heme into ferrous iron, carbon monoxide (CO), and biliverdin (BV), the latter being subsequently converted into bilirubin...

      Heme oxygenase (HO)-1 is an inducible enzyme that catalyzes
      the first and rate-limiting step in the oxidative degradation
      of free heme into ferrous iron, carbon monoxide (CO),
      and biliverdin (BV), the latter being subsequently converted
      into bilirubin (BR). HO-1, once expressed during inflammation,
      forms high concentrations of its enzymatic by-products
      that can influence various biological events, and this expression
      is proven to be associated with the resolution of
      inflammation. The degradation of heme by HO-1 itself, the
      signaling actions of CO, the antioxidant properties of
      BV/BR, and the sequestration of ferrous iron by ferritin all
      concertedly contribute to the anti-inflammatory effects of
      HO-1. This review focuses on the anti-inflammatory mechanisms
      of HO-1 actions and its roles in inflammatory diseases.

      더보기

      다국어 초록 (Multilingual Abstract)

      Heme oxygenase (HO)-1 is an inducible enzyme that catalyzes the first and rate-limiting step in the oxidative degradation of free heme into ferrous iron, carbon monoxide (CO), and biliverdin (BV), the latter being subsequently converted into bilir...

      Heme oxygenase (HO)-1 is an inducible enzyme that catalyzes
      the first and rate-limiting step in the oxidative degradation
      of free heme into ferrous iron, carbon monoxide (CO),
      and biliverdin (BV), the latter being subsequently converted
      into bilirubin (BR). HO-1, once expressed during inflammation,
      forms high concentrations of its enzymatic by-products
      that can influence various biological events, and this expression
      is proven to be associated with the resolution of
      inflammation. The degradation of heme by HO-1 itself, the
      signaling actions of CO, the antioxidant properties of
      BV/BR, and the sequestration of ferrous iron by ferritin all
      concertedly contribute to the anti-inflammatory effects of
      HO-1. This review focuses on the anti-inflammatory mechanisms
      of HO-1 actions and its roles in inflammatory diseases.

      더보기

      참고문헌 (Reference)

      1 Maines MD, "function, multiplicity, regulatory mechanisms, and clinical applications" 2 : 2557-2568, 1988

      2 Kim EH, "Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells" 1090 : 375-384, 2006

      3 Suzuki T, "Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome" 60 : 275-283, 2000

      4 Ollinger R, "Therapeutic applications of bilirubin and biliverdin in transplantation" 9 : 2175-2185, 2007

      5 Ryter SW, "The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties" 28 : 289-309, 2000

      6 Megías J, "The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells" 150 : 977-986, 2007

      7 Hu CM, "Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice" 56 : 1240-1247, 2007

      8 George JF, "Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells" 173 : 154-160, 2008

      9 Takamiya R, "Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role" 283 : H861-H870, 2002

      10 Moreto V, "Role of heme-oxygenase pathway on vasopressin deficiency during endotoxemic shock-like conditions" 26 : 472-476, 2006

      1 Maines MD, "function, multiplicity, regulatory mechanisms, and clinical applications" 2 : 2557-2568, 1988

      2 Kim EH, "Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells" 1090 : 375-384, 2006

      3 Suzuki T, "Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome" 60 : 275-283, 2000

      4 Ollinger R, "Therapeutic applications of bilirubin and biliverdin in transplantation" 9 : 2175-2185, 2007

      5 Ryter SW, "The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties" 28 : 289-309, 2000

      6 Megías J, "The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells" 150 : 977-986, 2007

      7 Hu CM, "Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice" 56 : 1240-1247, 2007

      8 George JF, "Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells" 173 : 154-160, 2008

      9 Takamiya R, "Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role" 283 : H861-H870, 2002

      10 Moreto V, "Role of heme-oxygenase pathway on vasopressin deficiency during endotoxemic shock-like conditions" 26 : 472-476, 2006

      11 Poole B, "Role of heme oxygenase-1 in endotoxemic acute renal failure" 289 : F1382-F1385, 2005

      12 Willoughby DA, "Resolution of inflammation" 22 : 1131-1135, 2000

      13 Tracz MJ, "Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice" 170 : 1820-1830, 2007

      14 Kobayashi H, "Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis" 54 : 1132-1142, 2006

      15 Yao P, "Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways" 47 : 253-261, 2007

      16 Tamion F, "Protective effects of heme-oxygenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10" 61 : 1078-1084, 2006

      17 Nakao A, "Protective effect of carbon monoxide in transplantation" 10 : 650-671, 2006

      18 Abraham NG, "Pharmacological and clinical aspects of heme oxygenase" 60 : 79-127, 2008

      19 Bédard EL, "Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection" 18 : 341-349, 2005

      20 Khor TO, "Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis" 66 : 11580-11584, 2006

      21 Li M, "Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice" 6 : 567-571, 2007

      22 Laumonier T, "Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig" 16 : 404-410, 2008

      23 Tamion F, "Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model" 293 : G1308-G1314, 2007

      24 Li M, "Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin" 9 : 855-863, 2007

      25 Martins PN, "Induction of heme oxygenase-1 in the donor reduces graft immunogenicity" 37 : 384-386, 2005

      26 Becker T, "Induction of heme oxygenase-1 improves the survival of pancreas grafts by prevention of pancreatitis after transplantation" 84 : 1644-1655, 2007

      27 Martins PN, "Induction of carbon monoxide in the donor reduces graft immunogenicity and chronic graft deterioration" 37 : 379-381, 2005

      28 Baecher-Allan C, "Human regulatory T cells and their role in autoimmune disease" 212 : 203-216, 2006

      29 Koizumi S, "Human heme oxygenase-1 deficiency: a lesson on serendipity in the discovery of the novel disease" 49 : 125-132, 2007

      30 Balla J, "Heme, heme oxygenase and ferritin in vascular endothelial cell injury" 49 : 1030-1043, 2005

      31 Ryter SW, "Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance" 234 : 249-263, 2002

      32 Takahashi T, "Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation" 7 : 745-753, 2007

      33 Ryter SW, "Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications" 86 : 583-650, 2006

      34 Chung SW, "Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice" 118 : 239-247, 2008

      35 Lee SS, "Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells" 21 : 3450-3457, 2007

      36 Liu Y, "Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis" 12 : 1841-1845, 2001

      37 Soares MP, "Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation" 172 : 3553-3563, 2004

      38 Kapturczak MH, "Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse" 165 : 1045-1053, 2004

      39 Zelenay S, "Heme oxygenase-1 is not required for mouse regulatory T cell development and function" 19 : 11-18, 2007

      40 Yamashita K, "Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs" 20 : 776-778, 2006

      41 Maeda S, "Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation" 4 : 663-667, 2008

      42 Chakrabarty A, "Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis" 9 : 372-381, 2003

      43 Zhen-Wei X, "Heme oxygenase-1 improves the survival of discordant cardiac xenograft through its anti-inflammatory and anti-apoptotic effects" 11 : 850-859, 2007

      44 Kawashima A, "Heme oxygenase-1 deficiency: the first autopsy case" 33 : 125-130, 2002

      45 Xia ZW, "Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membranebound transforming growth factor-1" 171 : 1904-1914, 2007

      46 Wagner M, "Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts" 63 : 1564-1573, 2003

      47 Bach FH, "Heme oxygenase-1 and transplantation tolerance" 67 : 430-432, 2006

      48 Pae HO, "Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy" 2 : 159-165, 2008

      49 Chora AA, "Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation" 117 : 438-447, 2007

      50 Almolki A, "Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs" 287 : L26-L34, 2004

      51 Kirino M, "Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice:implications for human disease" 122 : 290-297, 2008

      52 Farombi EO, "Heme Oxygenase-1 as a Potential Therapeutic Target for Hepatoprotection" 한국생화학분자생물학회 39 (39): 479-491, 2006

      53 Rushworth SA, "Haem oxygenase-1 in inflammation" 32 : 1093-1094, 2004

      54 Chang KY, "HO-1 mediates the effects of HBO pretreatment against sepsis" 136 : 143-153, 2006

      55 Immenschuh S, "Gene regulation of heme oxygenase-1 as a therapeutic target" 60 : 1121-1128, 2000

      56 Kumar S, "Free heme toxicity and its detoxification systems in human" 157 : 175-188, 2005

      57 Aust SD, "Ferritin as a source of iron and protection from iron-induced toxicities" 83 : 941-944, 1995

      58 Mohri T, "Enhanced expression of intracellular heme oxygenase-1 in deactivated monocytes from patients with severe systemic inflammatory response syndrome" 61 : 616-623, 2006

      59 Wiesel P, "Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice" 102 : 3015-3022, 2000

      60 Shen WL, "Elevated catalase and heme oxygenase-1 may contribute to improved postischaemic cardiac function in long-term type 1 diabetes" 35 : 820-826, 2008

      61 Tu CF, "Effects of heme oxygenase-1 transgenic islets on transplantation" 37 : 3463-3467, 2005

      62 Jeong Un Jang, "Effects of Heme Oxygenase-1 Inducer and Inhibitor on Experimental Autoimmune Uveoretinitis" 대한안과학회 21 (21): 238-243, 2007

      63 Wang H, "Donor treatment with carbon monoxide can yield islet allograft survival and tolerance" 54 : 1400-1406, 2005

      64 Wagener FA, "Different faces of the heme-heme oxygenase system in inflammation" 55 : 551-571, 2003

      65 Tracz MJ, "Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia" 72 : 1073-1080, 2007

      66 Schnickel GT, "Cytoprotective gene HO-1 and chronic rejection in heart transplantation" 38 : 3259-3262, 2006

      67 Schaer CA, "Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin" 99 : 943-950, 2006

      68 Pae HO, "Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production" 172 : 4744-4751, 2004

      69 Vannacci A, "Carbon monoxide modulates the response of human basophils to FcepsilonRI stimulation through the heme oxygenase pathway" 465 : 289-297, 2003

      70 Otterbein LE, "Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway" 6 : 422-428, 2000

      71 Sato K, "Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants" 166 : 4185-4194, 2001

      72 Suh GY, "CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2" 35 : 220-226, 2006

      73 Yamashita K, "Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts" 18 : 765-767, 2004

      74 Sarady-Andrews JK, "Biliverdin administration protects against endotoxin-induced acute lung injury in rats" 289 : L1131-L1137, 2005

      75 Kobayashi T, "Augmentation of heme oxygenase-1 expression in the graft immediately after implantation in adult living-donor liver transplantation" 79 : 977-980, 2005

      76 Owuor ED, "Antioxidants and oxidants regulated signal transduction pathways" 64 : 765-770, 2002

      77 Du D, "Adenovirusmediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants" 39 : 3446-3448, 2007

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2025 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2022-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2021-12-01 평가 등재로 하락 (재인증) KCI등재
      2016-02-22 학회명변경 영문명 : Korean Association Of Immunbiologists -> The Korean Association of Immunologists
      2016-01-01 평가 우수등재학술지 선정 (계속평가)
      2012-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2009-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2008-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보학술지 유지 (등재후보2차) KCI등재후보
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.36 0.36 0.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.24 0.2 0.636 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼